Please assess the completion status of the following clinical trial:

Trial Title: Spinal Cord Stimulation in Hypotensive Heart Failure Patients: Hemodynamic Assessment

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18-75 years.~2. Patients with heart failure III-IV functional class (NYHA) with indications to right heart catheterization.~3. Systolic blood pressure \<110/70 mm Hg when measured while sitting.~4. Patient who signed an informed consent form.~Exclusion Criteria:~1. Hypovolemic status (central venous pressure \<2 mm Hg).~2. Any acute illness.~3. Transient ischemic event or stroke within 2 weeks prior to inclusion.~4. Pulmonary embolism \<1 month ago.~5. Epilepsy.~6. An implanted infusion pump.~7. Pacemaker-dependent patients.~8. Patients who have contraindications to the use of the patch electrodes used in this study, as indicated in the respective instructions for use.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Spinal cord stimulation in heart failure patients with hypotension (Type: EXPERIMENTAL): Adhesive patches are applied to subjects' back skin. Single stimuli are delivered in order to define the stimulation threshold under the guidance of neuromyography. Vascular access is performed (jugular or subclavian) according to conventional preparation to right heart catheterization. Invasive hemodynamic measures are performed as usual.~High-frequency spinal cord stimulation at T5 level is initiated, and repeated hemodynamic measures performed within 2 minutes. Stimulation lasts for 5-10 minutes, and then ceased. Following a 5-minutes waiting period, repeat hemodynamic measures are performed. The same sequence of steps applies for stimulation levels T7-8 and a combination of T5 and T7-8.~Then the procedure is completed and data are analysed.

Based on this trial design, predict the completion outcome and termination type (if applicable).